Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Conditions:   Pulmonary Embolism;   Embolism;   Embolism and Thrombosis;   Lung Diseases;   Cardiovascular Diseases;   Respiratory Tract Diseases;   Venous Thromboembolism;   Anticoagulant-induced Bleeding;   Bleeding Interventions:   Drug: Rivaroxaban;   Drug: Placebo Sponsors:   University Hospital Inselspital, Berne;   University of Bern;   Schweizerischer Nationalfonds;   Leiden University Medical Center;   The Ottawa Hospital;   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials